Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Study of Atherosclerosis With Ramipril and Rosiglitazone

NCT00140647 is registered in ClinicalTrials.gov with Gerstein, Hertzel, MD as lead sponsor.

NCT NCT00140647
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00140647 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Study of Atherosclerosis With Ramipril and Rosiglitazone
Lead sponsor
Gerstein, Hertzel, MD
Phase
Phase 3
Overall status
Completed
Start date
July 31, 2001
Completion date
July 31, 2006
Enrollment
1,200
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

atherosclerosis, cardiovascular disease, impaired glucose tolerance, isolated impaired fasting glucose